Skip to main content

and
Your search also matched 4 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer

Include preview-only content
  1. Article

    Open Access

    Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial

    Supraclavicular nodal (SCL) irradiation is commonly used for patients with high-risk breast cancer after breast surgery. The Radiation Therapy Oncology Group (RTOG) and European Society for Radiotherapy and On...

    Li Zhang, **n Mei, Zhigang Hu, Bo Yu, Chaoyang Zhang, Yong Li, Kaitai Liu in BMC Cancer (2024)

  2. Article

    Open Access

    Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesions

    Breast cancer brain metastases (BCBM) are highly heterogenous with widely differing survival. The prognosis of the oligometastatic breast cancer (BC) patients with brain metastases (BM) has not been well studi...

    Wei Shi, Yang Li, Hua Sun, Li Zhang, ** Meng, **aofang Wang in Radiation Oncology (2023)

  3. Article

    Open Access

    A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose

    This study aimed to compare the adverse reactions of conventional-dose and hypofractionated dose of proton therapy for breast cancer.

    ZhengShan Hong, ZhaoZhi Yang, **n Mei, ** Li, Cihang Bao in Radiation Oncology (2023)

  4. Article

    Open Access

    Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?

    Postmastectomy radiation therapy (PMRT) in T1–T2 tumors with 1–3 positive axillary lymph nodes (ALNs) is controversial. This study was to identify prognostic factors of locoregional control (LRC) following mas...

    **aofang Wang, Li Zhang, **aomeng Zhang, Jurui Luo in Breast Cancer Research and Treatment (2021)

  5. Article

    Open Access

    CDK4/6 inhibitors: a novel strategy for tumor radiosensitization

    Recently, the focus of enhancing tumor radiosensitivity has shifted from chemotherapeutics to targeted therapies. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors are a novel class of selective cell cycle t...

    Yilan Yang, Jurui Luo, **ngxing Chen in Journal of Experimental & Clinical Cancer … (2020)

  6. Article

    Open Access

    Targeting deubiquitinase USP28 for cancer therapy

    As one of the most important post-translational modifications, ubiquitination plays versatile roles in cancer-related pathways, and is involved in protein metabolism, cell-cycle progression, apoptosis, and tra...

    **aofang Wang, Zhiyi Liu, Li Zhang, Zhaozhi Yang, in Cell Death & Disease (2018)

  7. Article

    Open Access

    Is it possible for knowledge-based planning to improve intensity modulated radiation therapy plan quality for planners with different planning experiences in left-sided breast cancer patients?

    Knowledge-based planning (KBP) is a promising technique that can improve plan quality and increase planning efficiency. However, no attempts have been made to extend the domain of KBP for planners with differe...

    Juanqi Wang, Weigang Hu, Zhaozhi Yang, **aohui Chen, Zhiqiang Wu in Radiation Oncology (2017)

  8. Article

    Open Access

    Dosimetric impact of different bladder and rectum filling during prostate cancer radiotherapy

    The aim of this study was to analyze the influence of volumetric changes of bladder and rectum filling on the 3D dose distribution in prostate cancer radiotherapy.

    Zhi Chen, Zhaozhi Yang, Jiazhou Wang, Weigang Hu in Radiation Oncology (2016)